These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 28636277)
1. ESRRB plays a crucial role in the promotion of porcine cell reprograming. Yang F; Ren Y; Li H; Wang H J Cell Physiol; 2018 Feb; 233(2):1601-1611. PubMed ID: 28636277 [TBL] [Abstract][Full Text] [Related]
2. Spermatogonial stem cells and progenitors are refractory to reprogramming to pluripotency by the transcription factors Oct3/4, c-Myc, Sox2 and Klf4. Corbineau S; Lassalle B; Givelet M; Souissi-Sarahoui I; Firlej V; Romeo PH; Allemand I; Riou L; Fouchet P Oncotarget; 2017 Feb; 8(6):10050-10063. PubMed ID: 28052023 [TBL] [Abstract][Full Text] [Related]
3. Overexpression Nanog activates pluripotent genes in porcine fetal fibroblasts and nuclear transfer embryos. Zhang L; Luo YB; Bou G; Kong QR; Huan YJ; Zhu J; Wang JY; Li H; Wang F; Shi YQ; Wei YC; Liu ZH Anat Rec (Hoboken); 2011 Nov; 294(11):1809-17. PubMed ID: 21972213 [TBL] [Abstract][Full Text] [Related]
4. OSKM Induce Extraembryonic Endoderm Stem Cells in Parallel to Induced Pluripotent Stem Cells. Parenti A; Halbisen MA; Wang K; Latham K; Ralston A Stem Cell Reports; 2016 Apr; 6(4):447-455. PubMed ID: 26947975 [TBL] [Abstract][Full Text] [Related]
9. Esrrb activates Oct4 transcription and sustains self-renewal and pluripotency in embryonic stem cells. Zhang X; Zhang J; Wang T; Esteban MA; Pei D J Biol Chem; 2008 Dec; 283(51):35825-33. PubMed ID: 18957414 [TBL] [Abstract][Full Text] [Related]
10. Activin-SMAD signaling is required for maintenance of porcine iPS cell self-renewal through upregulation of NANOG and OCT4 expression. Yang F; Wang N; Wang Y; Yu T; Wang H J Cell Physiol; 2017 Aug; 232(8):2253-2262. PubMed ID: 27996082 [TBL] [Abstract][Full Text] [Related]
11. NKX3-1 is required for induced pluripotent stem cell reprogramming and can replace OCT4 in mouse and human iPSC induction. Mai T; Markov GJ; Brady JJ; Palla A; Zeng H; Sebastiano V; Blau HM Nat Cell Biol; 2018 Aug; 20(8):900-908. PubMed ID: 30013107 [TBL] [Abstract][Full Text] [Related]
12. Activation of pluripotency-associated genes in mouse embryonic fibroblasts by non-viral transfection with in vitro-derived mRNAs encoding Oct4, Sox2, Klf4 and cMyc. Tavernier G; Wolfrum K; Demeester J; De Smedt SC; Adjaye J; Rejman J Biomaterials; 2012 Jan; 33(2):412-7. PubMed ID: 21993235 [TBL] [Abstract][Full Text] [Related]
13. Generation of pig iPS cells: a model for cell therapy. Montserrat N; Bahima EG; Batlle L; Häfner S; Rodrigues AM; González F; Izpisúa Belmonte JC J Cardiovasc Transl Res; 2011 Apr; 4(2):121-30. PubMed ID: 21088946 [TBL] [Abstract][Full Text] [Related]
14. Screening of Human cDNA Library Reveals Two differentiation-Related Genes, HHEX and HLX, as Promoters of Early Phase Reprogramming toward Pluripotency. Yamakawa T; Sato Y; Matsumura Y; Kobayashi Y; Kawamura Y; Goshima N; Yamanaka S; Okita K Stem Cells; 2016 Nov; 34(11):2661-2669. PubMed ID: 27335261 [TBL] [Abstract][Full Text] [Related]
15. The timing of retroviral silencing correlates with the quality of induced pluripotent stem cell lines. Okada M; Yoneda Y Biochim Biophys Acta; 2011 Feb; 1810(2):226-35. PubMed ID: 20965232 [TBL] [Abstract][Full Text] [Related]
16. Critical POU domain residues confer Oct4 uniqueness in somatic cell reprogramming. Jin W; Wang L; Zhu F; Tan W; Lin W; Chen D; Sun Q; Xia Z Sci Rep; 2016 Feb; 6():20818. PubMed ID: 26877091 [TBL] [Abstract][Full Text] [Related]
17. An integrated systems biology approach identifies positive cofactor 4 as a factor that increases reprogramming efficiency. Jo J; Hwang S; Kim HJ; Hong S; Lee JE; Lee SG; Baek A; Han H; Lee JI; Lee I; Lee DR Nucleic Acids Res; 2016 Feb; 44(3):1203-15. PubMed ID: 26740582 [TBL] [Abstract][Full Text] [Related]
18. Oct4-enhanced green fluorescent protein transgenic pigs: a new large animal model for reprogramming studies. Nowak-Imialek M; Kues WA; Petersen B; Lucas-Hahn A; Herrmann D; Haridoss S; Oropeza M; Lemme E; Schöler HR; Carnwath JW; Niemann H Stem Cells Dev; 2011 Sep; 20(9):1563-75. PubMed ID: 21126163 [TBL] [Abstract][Full Text] [Related]